Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.
about
Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue diseaseQuantification of HTLV-I proviral load in experimentally infected rabbitsRates of CTL killing in persistent viral infection in vivoCandidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.Soluble IL-2 receptor and beta-2 microglobulin as possible serologic markers of neurologic disease in HTLV-1 infection.Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriersIL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1.BLV-CoCoMo-qPCR: Quantitation of bovine leukemia virus proviral load using the CoCoMo algorithm.Evaluation of HTLV-1 activity in HAM/TSP patients using proviral load and Tax mRNA expression after In Vitro lymphocyte activation.Functional activity of monocytes and macrophages in HTLV-1 infected subjects.Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosisTranscription regulatory complexes bind the human T-cell leukemia virus 5' and 3' long terminal repeats to control gene expression.Adult T cell leukemia lymphoma.Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran.Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study.In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infectionImmunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infectionMAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.Association of Sicca Syndrome with Proviral Load and Proinflammatory Cytokines in HTLV-1 Infection.Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals.Neurological symptoms and signs in HTLV-1 patients with overactive bladder syndromeGAPDH Pseudogenes and the Quantification of Feline Genomic DNA Equivalents.Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes.One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, and 3.In-house HIV-1 RNA real-time RT-PCR assays: principle, available tests and usefulness in developing countries.Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.Antigenic stimulation specifically reactivates the replication of archived simian immunodeficiency virus genomes in chronically infected macaquesSerological and Molecular Methods to Study Epidemiological Aspects of Human T-Cell Lymphotropic Virus Type 1 Infection.Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.Oral health profile in patients infected with HTLV-1: clinical findings, proviral load, and molecular analysis from HTLV-1 in saliva.Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients.High risk of heterosexual transmission of human T-cell lymphotropic virus type 1 infection in Brazil.Detection of anatid herpesvirus 1 gC gene by TaqMan fluorescent quantitative real-time PCR with specific primers and probe.Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination.
P2860
Q24805302-D5D20C2D-8BB4-49EB-9306-77AFA6E8A489Q24811582-21ACF491-52D7-4C1B-B570-3FF54B8546A6Q27322823-EB950F18-DE65-4AD7-9271-ECC4F532C0EEQ33388659-1B840101-182A-47AE-A1C8-B7B3CB95ABA5Q33777159-C5BCD636-98EB-42F6-B721-A13F11721562Q33856274-51109B35-A44B-4CB4-8C80-8A8F4D1A718DQ34105919-9FB0971F-594C-48EC-852E-9DE48846FDBCQ34214760-8F49D856-9C06-4869-88E3-B300DB7FAC19Q34237242-E0696C03-80E9-4A40-A09C-543299DB3C8EQ34335307-810BF185-1145-4702-A3E8-94D9F3915764Q34567129-4F948A72-4DA1-4B9C-8F7B-9D8254F1BA9BQ34733818-580C0858-7D57-4EAC-8318-C5E652E6C584Q35103232-31590ED7-7F32-4F07-8D34-F9E481E4E821Q35126347-FB51F28D-AC96-40AD-8966-D3995135E0FFQ35880693-8AA1BB7E-11C5-4A1D-9542-3F98FC11854CQ35964941-3DE41C3F-7EA3-461F-B032-3DBC4EB6786BQ35975547-A5C93D57-EC57-41E1-9F1B-1C51D20B9CDBQ36110061-672CD61D-4B38-4A82-A47F-6B35BB2019F9Q36277748-DDFE5219-9400-46CD-A7D3-BD215E58B9D4Q36338406-7CA1685D-E3AB-4FDB-AB6D-83D79964339FQ36556456-1F381C00-DFF8-4755-9343-EB70F32E2189Q36690145-854E3585-7AC6-4774-8D26-C276F510085CQ36769136-34A0D594-F599-44EB-979D-C6C061945715Q36848758-1D9EC221-2DED-463F-B94F-28705EBDE722Q36995018-2A32494A-4209-4A3A-A601-D18ABF8F6E46Q37067623-112E5BEC-A6B7-425B-ABA9-7522A9BA170DQ37156805-44E0856F-6667-4ACC-BF9A-A82845601981Q37266495-EEED9CE3-8820-4574-B514-DC645AFB14B2Q37511446-B83419A4-731A-4DDF-89D8-DFA8FD312105Q38441445-5AEE92F5-875D-4C30-9C89-2AF21E44B5F9Q38867778-82E2F91F-8348-4024-95A2-ED5D0D6505C0Q38906684-43F1EE6C-D95B-4856-90E5-F35F68DB06B2Q39031445-F277FE7F-34C9-4FA8-8636-C69833257DFDQ39182385-02337265-2C28-435C-800B-5017493A1BA9Q39263618-1C612B54-B346-4703-BF20-F729C8D0987EQ39294381-7817B05B-4316-41A9-863C-530EC68F81C3Q39303790-9C068E4B-CCD3-4B66-815F-68A146C79E74Q39333941-C1FED3AF-FAEE-43AE-857D-FB72E6FF5EAEQ39594070-CB329D2A-4317-460B-A72D-01B77892EBB3Q39801440-A50A71C0-F9BB-4083-9FE3-4676E53B49A2
P2860
Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.
@en
type
label
Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.
@en
prefLabel
Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.
@en
P2093
P1476
Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.
@en
P2093
Agnès Lézin
Axelle Dehée
Didier Smadja
Jean Claude Nicolas
Nathalie Désiré
Odile Béra
Olivier Bourdonné
Yves Plumelle
P356
10.1016/S0166-0934(01)00445-1
P577
2002-04-01T00:00:00Z